Sun Pharma sees huge expansion opportunities in PunjabSun Pharma today said it sees immense opportunities for expansion in Punjab even as its focus is on bringing Ranbaxy facilities to complian...
28 Oct, 2015, 10.53 PM IST
Ranbaxy Laboratories recalls 29,790 packs of anti-allergy drug in USRanbaxy Laboratories is recalling 29,790 blister packs of anti-allergy drug in the US, manufactured by its arm Ohms Laboratories, due to de...
02 May, 2014, 08.08 PM IST
Certain consent decree terms to apply to Mohali unit: RanbaxyThe decree contains provisions to ensure CGMP (Current Good Manufacturing Practices) compliance at certain Ranbaxy facilities.
17 Sep, 2013, 05.20 PM IST
DCGI asked to check quality of drugs sold by Ranbaxy: GovernmentThe government today said it has ordered the Drug Controller General of India (DCGI) to check the quality of drugs produced by Ranbaxy Labo...
23 Aug, 2013, 02.32 PM IST
Ranbaxy allocated site for manufacturing facility in MalaysiaThe facility will be built on an area of around 15 acres with an investment of over Rs 200 crore providing employment to over 200 people.
08 Aug, 2013, 01.21 PM IST
Ranbaxy facilities under review: Gulam Nabi AzadRanbaxy facilities in India are being reviewed after its US arm admitted to manufacturing certain drugs not in conformity with good practic...
06 Aug, 2013, 08.18 PM IST
'Former Ranbaxy shareholders hid key info on US investigation'Ranbaxy's Japanese promoters today blamed the company's former Indian owners for concealing and misrepresenting critical information about ...
22 May, 2013, 09.03 PM IST
Ranbaxy has taken steps to ensure quality control: Arun SawhneyRanbaxy Laboratories today said it has taken several steps in recent years to ensure safety and efficacy of its products in the global mark...
22 May, 2013, 05.32 PM IST
Govt probed US FDA charges on Ranbaxy in 2008, but didn’t ban itThe health ministry decided not to toe the US FDA's line because of three reasons cited in a report prepared by Drug Controller General of ...
22 May, 2013, 05.00 AM IST
No plans to change Ranbaxy's name, says Daiichi SankyoRanbaxy’s Japanese parent Daiichi Sankyo has no plans to change the name of the company or delist it from the stock exchange at the moment.
22 May, 2013, 05.00 AM IST
Ranbaxy to pay $500 mn to US Department of Justice for settlement of felony charges related to drug safetyRanbaxy pleaded guilty to felony charges related to drug safety & will pay $500 mn in fines under settlement agreement with US Department o...
14 May, 2013, 06.58 PM IST
- Ranbaxy Laboratories to set up second plant in Malaysia at $40 million investment
Ranbaxy Malaysia Sdn Bhd got approval for setting up a greenfield manufacturing facility in Malaysia as an Entry Point Project.
13 Sep, 2012, 06.00 PM IST
- Ranbaxy hires consultants as part of consent decree with USFDA
Drug major Ranbaxy Laboratories said it has hired two US-based consultants to advise it on remedial work to be done at its manufacturing un...
25 May, 2012, 02.09 PM IST
- Ranbaxy opens new manufacturing facility in Morocco; eyes $1 bn drug market
Ranbaxy has opened a new production facility in Morocco, a move which would help the drug maker access the African nation's $1 billion phar...
12 Mar, 2012, 03.04 PM IST
- Ranbaxy signs consent decree with FDA, may pay upto $500 million penalty
Ranbaxy has signed a consent decree with the US FD and has set aside a $500 million for penalty which will allow the Indian drug maker to r...
21 Dec, 2011, 09.52 AM IST
- US regulator blocks entry of 30 Ranbaxy medicines
In a severe setback for Ranbaxy, the US FDA has banned entry in the US of over 30 medicines manufactured by the drug maker at two of its In...
18 Sep, 2008, 04.29 AM IST
- Ranbaxy units face FDA heat after inspections
Sources said that USFDA has given a ‘not approved’ rating to new products manufactured at the facility, although this could not be independ...
02 Jul, 2008, 03.42 AM IST